NRx Pharmaceuticals files $20M ATM offering for common stock

NRX Pharmaceuticals, Inc.

Filed prospectus supplement for up to $20M of common stock via ATM with H.C. Wainwright & Co.
Shares to be issued under S-3 registration statement declared effective December 22, 2025.
Legal opinion from Cozen O'Connor on share validity filed as Exhibit 5.1.
No specific sales, pricing, or use of proceeds disclosed in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.